PFE and BMY Related Headlines

Go Back

Mar 31, 2016 12:04AM Decline in financial settlements with U.S. Big Pharma: report
Mar 30, 2016 07:46AM Pfizer (PFE), Bristol-Myers Squibb (BMY) Will Present 16 Abstracts at ACC.16
Feb 12, 2016 12:29PM Intercept Pharma (ICPT) Said to Explore Sale Following Interest
Feb 4, 2016 02:27AM AstraZeneca warns on profits in 2016 as Crestor patent loss weighs
Feb 3, 2016 06:58AM Merck gives cautious 2016 outlook as sales of top medicines lag
Feb 2, 2016 09:54AM Intercept Pharma (ICPT) on Watch Following Rumors Out of UK
Feb 1, 2016 06:56AM Portola Pharma (PTLA) Enters Licensing Agreements for Investigational Agent Andexanet in Japan (BMY) (PFE)
Jan 14, 2016 08:00AM Novartis (NVS) Named Top Global Pharma Pick at Jefferies
Dec 18, 2015 06:35AM ViiV Healthcare to Acquire Bristol-Myers Squibb's (BMY) Investigational HIV Medicines Pipeline
Dec 10, 2015 04:25PM Bristol-Myers Squibb (BMY) , Pfizer (PFE) Announce Encouraging Post-Hoc Data from Phase 3 AMPLIFY in VTE
Oct 27, 2015 06:53AM Top U.S. drugmakers ride new products to strong results
Aug 24, 2015 08:20AM Bristol-Myers Squibb (BMY), Pfizer (PFE) to Present Eliquis Data at ESC Congress
Jul 31, 2015 09:57AM Bristol-Myers Squibb (BMY) Active Amid Unconfirmed Chatter
Jun 22, 2015 08:47AM Portola Pharma (PTLA), Bristol-Myers (BMY), Pfizer (PFE) Announce Second Part of Phase 3 ANNEXA-A Met All Primary, Secondary Endpoints

PFE and BMY Related Press Releases

Go Back

Mar 30, 2016 07:45AM Bristol-Myers Squibb and Pfizer Announce Global Real-World Data Program and Present New Analyses of Eliquis (apixaban) at the American College of Cardiology’s 65th Annual Scientific Session
Feb 1, 2016 06:55AM Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan
Dec 15, 2015 08:00AM Alliance for Clinical Trials in Oncology and GNS Healthcare Launch Big Data Initiative to Transform Metastatic Colorectal Cancer Treatment
Dec 10, 2015 04:15PM AMPLIFY Post-Hoc Early Time Course Analysis Evaluated Recurrent Venous Thromboembolism (VTE), VTE-Related Death and Major Bleeding in Deep Vein Thrombosis and Pulmonary Embolism Patients Treated with
Nov 6, 2015 04:15PM Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the American Heart Association (AHA) Scientific Sessions 2015
Aug 24, 2015 08:15AM Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015
Jun 22, 2015 08:45AM Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect
Jun 22, 2015 08:45AM Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect

PFE and BMY Related SEC Filings

Go Back